Xponance’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$312K Buy
15,208
+1,060
+7% +$24.3K ﹤0.01% 1377
2026
Q1
$312K Buy
14,148
+2,266
+19% +$39.4K ﹤0.01% 1249
2025
Q4
$140K Buy
11,882
+65
+0.6% +$835 ﹤0.01% 1434
2025
Q3
$187K Buy
11,817
+84
+0.7% +$1.22K ﹤0.01% 1373
2025
Q2
$134K Buy
+11,733
New +$132K ﹤0.01% 1382
2025
Q1
Sell
-18,648
Closed -$315K 1459
2024
Q4
$315K Buy
18,648
+1,177
+7% +$22.9K ﹤0.01% 1113
2024
Q3
$355K Buy
17,471
+327
+2% +$6.68K ﹤0.01% 1037
2024
Q2
$387K Sell
17,144
-645
-4% -$16.9K ﹤0.01% 981
2024
Q1
$467K Buy
17,789
+164
+0.9% +$4.67K ﹤0.01% 961
2023
Q4
$556K Sell
17,625
-168
-0.9% -$4.56K 0.01% 899
2023
Q3
$499K Sell
17,793
-387
-2% -$13.3K 0.01% 893
2023
Q2
$671K Sell
18,180
-10,679
-37% -$326K 0.01% 794
2023
Q1
$864K Sell
28,859
-290
-1% -$9.55K 0.01% 697
2022
Q4
$893K Buy
29,149
+1,552
+6% +$46.6K 0.01% 673
2022
Q3
$680K Sell
27,597
-197
-0.7% -$6.5K 0.01% 712
2022
Q2
$890K Buy
27,794
+2,485
+10% +$91.4K 0.02% 618
2022
Q1
$797K Sell
25,309
-1,558
-6% -$48.7K 0.01% 684
2021
Q4
$902K Sell
26,867
-243
-0.9% -$7.57K 0.01% 649
2021
Q3
$788K Sell
27,110
-646
-2% -$20.9K 0.02% 672
2021
Q2
$966K Buy
27,756
+10,246
+59% +$339K 0.02% 613
2021
Q1
$489K Buy
17,510
+153
+0.9% +$4.07K 0.01% 794
2020
Q4
$430K Buy
17,357
+58
+0.3% +$1.38K 0.01% 810
2020
Q3
$362K Buy
17,299
+2,498
+17% +$48.2K 0.01% 790
2020
Q2
$227K Buy
+14,801
New +$187K 0.01% 922

Other funds holding CC

Xponance's CC Position: Q2 2026 in Review

Xponance increased its Chemours (CC) stake by 7.5% in Q2 2026, buying an estimated $24.3K and bringing the position to 15,208 shares worth $312K. The position accounts for ﹤0.01% of the portfolio, ranked #1377.

Xponance first reported a position in CC in Q2 2020 and has held it in 24 quarters since. The position peaked at $966K in Q2 2021. 469 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Xponance held 15,208 shares of Chemours worth $312K as of Q2 2026.
  • Xponance bought 1,060 Chemours shares in Q2 2026, an estimated $24.3K.
  • Chemours made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1377 holding.
  • Xponance first reported a position in Chemours in Q2 2020 and has held it in 24 quarters since.
  • Xponance's Chemours position peaked at $966K in Q2 2021.
  • 469 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.